SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Barbara Cvenkel, Andreja Nataša Kopitar, Alojz Ihan, Correlation Between Filtering Bleb Morphology, Expression of Inflammatory Marker HLA-DR by Ocular Surface, and Outcome of Trabeculectomy, Journal of Glaucoma, 2013, 22, 1, 15

    CrossRef

  2. 2
    Gert Laekeman, Steven Simoens, Johan Buffels, Michel Gillard, Thibert Robillard, Margherita Strolin Benedetti, Jean-Baptiste Watelet, Georges Liekendael, Liesbet Ghys, Martin Church, Continuous versus on-demand pharmacotherapy of allergic rhinitis: Evidence and practice, Respiratory Medicine CME, 2011, 4, 2, 51

    CrossRef

  3. 3
    Gert Laekeman, Steven Simoens, Johan Buffels, Michel Gillard, Thibert Robillard, Margherita Strolin Benedetti, Jean-Baptiste Watelet, Georges Liekendael, Liesbet Ghys, Martin Church, Continuous versus on-demand pharmacotherapy of allergic rhinitis: Evidence and practice, Respiratory Medicine, 2010, 104, 5, 615

    CrossRef

  4. 4
    Anjuli S Nayak, Mometasone furoate monohydrate nasal spray for the treatment of nasal congestion in allergic rhinitis, Expert Review of Clinical Immunology, 2008, 4, 2, 143

    CrossRef

  5. 5
    Günther Hochhaus, Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: Potential effects on clinical safety and efficacy, Clinical Therapeutics, 2008, 30, 1, 1

    CrossRef

  6. 6
    Robert A. Nathan, The pathophysiology, clinical impact, and management of nasal congestion in allergic rhinitis, Clinical Therapeutics, 2008, 30, 4, 573

    CrossRef

  7. 7
    Leonie S. van Rijt, Bart N. Lambrecht, Dendritic cells in Asthma: A target for novel therapeutics?, Drug Discovery Today: Therapeutic Strategies, 2006, 3, 3, 299

    CrossRef

  8. 8
    Ken-ichi Kanai, Kazuhito Asano, Tadashi Hisamitsu, Harumi Suzaki, Suppressive activity of epinastine hydrochloride on TARC production from human peripheral blood CD4+ T cells in-vitro, Journal of Pharmacy and Pharmacology, 2005, 57, 8
  9. 9
    S.S. Davis, R. Eccles, Nasal congestion: mechanisms, measurement and medications. Core information for the clinician, Clinical Otolaryngology & Allied Sciences, 2004, 29, 6
  10. 10
    Sien-Hung Yang, Chuang-Ye Hong, Chia-Li Yu, The stimulatory effects of nasal discharge from patients with perennial allergic rhinitis on normal human neutrophils are normalized after treatment with a new mixed formula of Chinese herbs, International Immunopharmacology, 2002, 2, 12, 1627

    CrossRef

  11. 11
    Jean Bousquet, Paul van Cauwenberge, Nikolai Khaltaev, Allergic Rhinitis and Its Impact on Asthma, Journal of Allergy and Clinical Immunology, 2001, 108, 5, S147

    CrossRef

  12. 12
    A. M. Vignola, J. Bousquet, Rhinitis and asthma: a continuum of disease?, Clinical & Experimental Allergy, 2001, 31, 5
  13. 13
    A. F. Holm, W. J. Fokkens, Topical corticosteroids in allergic rhinitis; effects on nasal inflammatory cells and nasal mucosa, Clinical & Experimental Allergy, 2001, 31, 4
  14. 14
    P. Van Cauwenberge, C. Bachert , G. Passalacqua , J. Bousquet , G. W. Canonica , S. R. Durham , W. J. Fokkens , P. H. Howarth , V. Lund , H.-J. Malling , N. Mygind , D. Passali , G. K. Scadding , D.-Y. Wang , Consensus statement on the treatment of allergic rhinitis, Allergy, 2000, 55, 2
  15. 15
    Toyoyuki Hanazawa, Julio D. Antuni, Sergei A. Kharitonov, Peter J. Barnes, Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis, Journal of Allergy and Clinical Immunology, 2000, 105, 1, 58

    CrossRef

  16. 16
    A. Kleinjan, A. F. Holm, M. D. Dijkstra, S. S. Boks, L.-A. F. Severijnen, P. G. Mulder, W. J. Fokkens, Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation, Clinical & Experimental Allergy, 2000, 30, 10
  17. 17
    Paul V. Williams, TREATMENT OF RHINITIS, Immunology and Allergy Clinics of North America, 2000, 20, 2, 369

    CrossRef

  18. 18
    William R. Lumry, A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis, Journal of Allergy and Clinical Immunology, 1999, 104, 4, s150

    CrossRef

  19. 19
    C. Bachert, P. Geveart, Effect of intranasal corticosteroids on release of cytokines and inflammatory mediators, Allergy, 1999, 54,
  20. 20
    Harold S. Nelson, Mechanisms of intranasal steroids in the management of upper respiratory allergic diseases, Journal of Allergy and Clinical Immunology, 1999, 104, 4, s138

    CrossRef

  21. 21
    Richard L. Mabry, Recent advances in pharmacotherapy of allergic rhinitis, Current Opinion in Otolaryngology & Head and Neck Surgery, 1999, 7, 6, 375

    CrossRef

  22. 22
    WJ Fokkens, JP Braat, JP Van De Merwe, H Hooijkaas, SE Overbeek, The effect of intranasal and inhaled corticosteroids in healthy volunteers on the number of circulating lymphocytes and lymphocyte subsets, Allergy, 1999, 54, 2
  23. 23
    Craig LaForce, Use of nasal steroids in managing allergic rhinitis, Journal of Allergy and Clinical Immunology, 1999, 103, 3, S388

    CrossRef

  24. 24
    Ahmad Kantar, Nicola Oggiano, Giovanni V. Coppa, Orazio Gabrielli, Pier L. Giorgi, Mariaflavia Nicora, Claudio Benvenuti, Oxatomide attenuates the priming capacity on polymorphonuclear leukocytes of nasal lavage fluid obtained after allergen challenge, Current Therapeutic Research, 1998, 59, 6, 395

    CrossRef

  25. 25
    Eli O. Meltzer, Alfredo A. Jalowayski, H.Alice Orgel, Alan G. Harris, Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray, Journal of Allergy and Clinical Immunology, 1998, 102, 1, 39

    CrossRef

  26. 26
    Gianni Marone, Milestones in the biology and pharmacology of histamine H1-receptor antagonists, Allergy, 1997, 52,
  27. 27
    Mindy Tsai, Stephen J. Galli, Mast Cells,
  28. 28
    Marsha Wills-karp, Role of Th2 Cells in the Allergic Diathesis,